Select Language

  • Home
  • The Compendium
  • Featured Issues
  • Media Library
  • Vaccine Resources
  • Advocacy
  • About
Navigation Menu
  • Home
  • The Compendium
  • Featured Issues
  • Media Library
  • Vaccine Resources
  • Advocacy
  • About

Location: KENYA

Impact of 10-valent pneumococcal conjugate vaccine introduction on pneumococcal carriage and antibiotic susceptibility patterns among children aged <5 years and adults with HIV infection, Kenya 2009-2013

May 30, 2019

By Kirthini Muralidharan

Sustaining pneumococcal vaccination after transitioning from Gavi support: a modelling and cost-effectiveness study in Kenya

May 22, 2019

By Kirthini Muralidharan

Childhood vaccination in Kenya: socioeconomic determinants and disparities among the Somali ethnic community

May 21, 2019

By Kirthini Muralidharan

Maternal education and immunization status among children in Kenya

May 17, 2019

By Kirthini Muralidharan

Indirect effect of 10-valent pneumococcal conjugated vaccine against adult pneumococcal pneumonia in rural Western Kenya

May 17, 2019

By Kirthini Muralidharan

Economic value of vaccinating geographically hard-to-reach populations with measles vaccine: a modeling application in Kenya

May 15, 2019

By Kirthini Muralidharan

Economic value of vaccinating geographically hard-to-reach populations with measles vaccine: a modeling application in Kenya

May 10, 2019

By Kirthini Muralidharan

Effect of 10-valent pneumococcal conjugate vaccine on invasive pneumococcal disease and nasopharyngeal carriage in Kenya

May 10, 2019

By Kirthini Muralidharan

Effect of 10-valent pneumococcal conjugate vaccine on the incidence of radiologically-confirmed pneumonia and clinical-defined pneumonia in Kenyan children: an interrupted time-series analysis

May 9, 2019

By Kirthini Muralidharan

A retrospective cohort study to quantify the contribution of health systems to child survival in Kenya: 1996-2014

September 5, 2018

By Kirthini Muralidharan

Posts navigation

Older posts

Web Policies      Translation Disclaimer

VoICE is a project of the International Vaccine Access Center at the Johns Hopkins Bloomberg School of Public Health, and is made possible with support from the Bill & Melinda Gates Foundation. We thank the many partners who have contributed their time, energy and expertise to VoICE.

Johns Hopkins Bloomberg School of Public Health
www.jhsph.edu/ivac

Please email the VoICE editor with any questions or comments.

  • Contact Us
  • twitter

Stay Connected

© 2023, The International Vaccine Access Center, Johns Hopkins Bloomberg School of Public Health. All rights reserved.
This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Cookie settingsACCEPT
Privacy & Cookies Policy

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.

Learn more from the Johns Hopkins University Privacy Statement.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Non-necessary
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.
SAVE & ACCEPT